Insurance giant UnitedHealth Group Inc. (UNH) is having a good day. Shares jumped more than 5% on Thursday, adding to a six-month run that's already pushed the stock up nearly 20%. The catalyst? A double dose of analyst love and some much-needed clarity on government payment rates.
Bank of America Securities upgraded UnitedHealth from Neutral to Buy on Thursday and raised its price target from $420 to $450. The move comes after a rocky start to the year. In January, the stock got hammered when federal regulators proposed a near-flat Medicare Advantage rate update — just a 0.09% net average payment increase, far below the 4% to 6% the industry was expecting. That proposal would have generated only about $700 million in additional payments for insurers, and investors weren't happy.
But sentiment flipped in April when the Centers for Medicare & Medicaid Services finalized the calendar year 2027 rate announcement. The final update called for a 2.48% payment increase, translating to more than $13 billion in additional funding for Medicare Advantage plans. That sparked a rally in managed-care stocks, and UnitedHealth has been riding that wave ever since.
On Thursday, a BofA analyst wrote that UnitedHealth could lead a broader managed care rally if healthcare utilization trends continue to moderate. The analyst added that improving medical cost trends and supportive near-term data points position the company for a favorable second-quarter earnings report. UnitedHealth already raised its fiscal 2026 adjusted earnings per share guidance from over $17.75 to more than $18.25, compared to the consensus of $17.86, thanks to easing medical costs.
Morgan Stanley also chimed in, raising its price forecast on UnitedHealth to $453 from $395 while maintaining an Overweight rating. The analyst noted that managed care stocks have been trending higher amid early signs of easing utilization trends. But the really eye-catching part of Morgan Stanley's note was the potential for AI-driven benefits. The firm said improvements across both revenue generation and cost efficiency could result in roughly 45% average earnings upside for managed care organizations. That's a big number, and it suggests the market might be underestimating how much technology can reshape the insurance business.
Not everyone is bullish, of course. In May, Berkshire Hathaway (BRK) liquidated its entire position in UnitedHealth, a move that raised some eyebrows. But for now, the Street seems focused on the improving fundamentals and the AI opportunity.
UnitedHealth shares were trading at $396.39 at the time of publication, up 5.14% on the day.
